Small Biotech Innovation Act

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [S. 5029 Introduced in Senate (IS)] <DOC> 118th CONGRESS 2d Session S. 5029 To amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exception from the Medicare drug price negotiation program. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES September 12, 2024 Mr. Cassidy introduced the following bill; which was read twice and referred to the Committee on Finance _______________________________________________________________________ A BILL To amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exception from the Medicare drug price negotiation program. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Small Biotech Innovation Act''. SEC. 2. RESEARCH AND DEVELOPMENT-INTENSIVE SMALL BIOTECH MANUFACTURER EXCEPTION FROM MEDICARE DRUG PRICE NEGOTIATION PROGRAM. Section 1192(d)(2) of the Social Secu…